TP53 and cervical carcinoma: In our present study, we showed the evidence that metformin upregulated DDR-1 expression inhibiting the proliferation of cervical cancer cells, promoting cervical cancer apoptosis and suppress cervical cancer xenograft tumor tissues growth in a dose-dependent manner along with activating p53.